Intramedullary Nails Market to Reach $1.7 Billion Globally by 2032 at 5.6% CAGR: Allied Market Research

The increasing demand for customized orthopedic implants, the rising preference for minimally invasive surgeries, and continuous innovations in implant design & materials are projected to drive the global intramedullary nails market’s growth during the forecast period. The North America region is predicted to witness prominent growth by 2032.

Wilmington, New Castle, Delaware, April 18, 2024 (GLOBE NEWSWIRE) — Allied Market Research has recently published a report, titled, Intramedullary Nails Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by Material, by Application, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032.” According to the report, the global intramedullary nails market generated $1 billion in 2022, and is anticipated to generate $1.7 billion by 2032, rising at a CAGR of 5.6% from 2023 to 2032. 

Prime Determinants of Growth 

The increasing prevalence of fractures, particularly among the aging population, rising preference for minimally invasive surgeries, and the growing demand for orthopedic implants are the factors expected to drive the growth of the global intramedullary nails market in the forecast period from 2023 to 2032. However, the intramedullary nailing procedures come with inherent risks and complications, such as iatrogenic fractures, implant-related issues, and infection, which may hinder market growth in the coming future. On the contrary, the ongoing advancements in surgical techniques, implant materials, & instrumentation and increasing focus on orthopedic care for elderly population are expected to offer remunerative opportunities for the expansion of the intramedullary nails market during the forecast period. 

Request Sample of the Report on Intramedullary Nails Market Forecast 2032: https://www.alliedmarketresearch.com/request-sample/A11434 

Report Coverage & Details: 

Report Coverage  Details 
Forecast Period  2023–2032 
Base Year  2022 
Market Size in 2022  $1 billion 
Market Size in 2032  $1.7 billion 
CAGR  5.6% 
No. of Pages in Report  350 
Segments covered  Product Type, Material, Application, End-user, and Region 
Drivers  Increasing demand for customized orthopedic implants  Growing preference for minimally invasive surgeries  Rising prevalence of fractures 
Opportunities  Advancements in surgical techniques and instrumentation  Continuous innovations in implant design and materials 
Restraints  Inherent risks and complications, such as infection and implant-related issues 

Procure Complete Report (350 Pages PDF with Insights, Charts, Tables, and Figures): https://www.alliedmarketresearch.com/checkout-final/intramedullary-nails-market-A11434 

Product Type: Upper Bone Extremities Sub-segment to Witness Significant Growth by 2032 

The upper bone extremities sub-segment accounted for the largest market share of 54.9% in 2022 and is predicted to continue to hold major market share by 2032. Continuous advancements in intramedullary nail designs, materials, and surgical techniques have led to improved patient outcomes and surgeon satisfaction. Additionally, the increasing incidence of upper extremity fractures among athletes and active individuals, driven by rising sports participation and recreational activities, has further propelled the demand for intramedullary nails as a reliable and efficient method of fracture stabilization, particularly for those seeking a rapid return to activity. 

Material: Titanium Sub-segment to Flourish Immensely During the Forecast Period 

The titanium sub-segment accounted for the largest intramedullary nails market share of 52.1% in 2022 and is expected to rise at the highest CAGR of 5.8% during the forecast period. This is majorly because titanium’s biologically inert nature and the protective surface layer of titanium dioxide make it a preferred biomaterial for implants. Its advantages, including exceptional biocompatibility, strength, and corrosion resistance, drive its significance in developed economies. Besides, being non-allergic, non-magnetic, and conveniently adherent to bone further contributes to its growing adoption. 

Application: Femoral Intramedullary Nail Sub-segment to be the Most Dominant During the Forecast Period 

The femoral intramedullary nail sub-segment held the largest intramedullary nails market share of 35.1% in 2022 and is expected to grow at the highest CAGR of 6.1% during the forecast period. As the global population ages and lifestyles evolve, the incidence of fractures, including femoral fractures, is expected to increase, driving the demand for orthopedic implants like intramedullary nails. Besides, ongoing advancements in surgical techniques, such as minimally invasive procedures and computer-assisted surgery, are accelerating the adoption of intramedullary nails by providing benefits like reduced surgical trauma, shorter recovery times, and improved patient outcomes. 

End-user: Hospitals Sub-segment to Witness Prominent Growth by 2032 

The hospitals sub-segment held the largest market share of 45.2% in 2022 and is projected to rise at the highest CAGR of 6.0% during the forecast period. This is mainly because hospitals cater to a significant portion of the population, particularly senior adults prone to femoral fractures due to age-related factors like osteoporosis. As the global population ages, hospitals witness increased demand for orthopedic interventions, including femoral intramedullary nailing, to address fractures in elderly patients. Besides, hospitals prioritize patient-centered care and aim to meet patient preferences and expectations regarding treatment options and outcomes. 

Region: North America Market to Hold Major Share by 2032 

The intramedullary nails market in the North America region accounted for the largest share of 33.5% in 2022 and is predicted to continue to maintain its dominance in terms of market share by 2032. This growth is mainly because orthopedic trauma and reconstruction device companies in the region have witnessed positive outcomes due to an increasing number of regulatory approvals, such as those obtained by Globus Medical, Inc., which received over eighty-two FDA product approvals. Besides, the growing attention in the region from government and private association collaborations has contributed to the market growth. 

Request For Custom Report: https://www.alliedmarketresearch.com/request-for-customization/A11434 

Leading Players in the Intramedullary Nails Market: 

  • Aysam Ortopedi & Tibbi Cihazlar 
  • Advanced Orthopaedic Solutions 
  • Johnson & Johnson 
  • B. Braun Melsungen AG 
  • Smith+Nephew 
  • Zimmer Biomet 
  • Orthofix Holdings, Inc. 
  • Wright Medical Group N.V. 
  • Stryker 
  • Orthopaedic Implant Company 

The report provides a detailed analysis of the key players of the global intramedullary nails market. These players have adopted different strategies, such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain their dominance in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 
David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy